Advisory Alpha, LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 33 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 7.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
Advisory Alpha, LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2019$950,000
-52.5%
5,0000.0%0.00%
-100.0%
Q1 2019$2,000,0005,0000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,825,000$1,206,0000.39%
Zhang Financial LLC 45,000$33,0000.02%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 472,553$313,0000.01%
MEITAV INVESTMENT HOUSE LTD 127,062$85,0000.01%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 324,479$215,000,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,588$200,0000.00%
Renaissance Technologies 1,993,500$1,318,0000.00%
WEDBUSH SECURITIES INC 15,000$10,0000.00%
TWO SIGMA SECURITIES, LLC 57,127$38,0000.00%
Psagot Value Holdings Ltd. 29,193$20,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders